Shijiazhuang No.4 Pharmaceutical Co., Ltd.

SSY Group Limited (Shijiazhuang No.4 Pharmaceutical Co., LTD.) is a large-scale high-tech pharmaceutical enterprise that develops harmoniously with R&D and industrialization in multiple fields of the industrial chain including innovative drugs, generic drugs, specialty APIs, high-end preparations and pharmaceutical packaging materials. The pharmaceutical industry ranked among the top 100 enterprises and among the outstanding brand enterprises for exporting preparations in China's chemical and pharmaceutical industry. In 2007, the company was listed on the Main Board of Hong Kong (SSY Group 02005.HK). For more than seventy years, the group has weathered the wind and rain and forged ahead. Especially in the past two decades, under the leadership of Mr. Qu Jiguang, the group leader, the company has transformed from a small workshop-style factory into a large listed company, and the company has achieved reborn changes and a qualitative leap. At present, the group has 10 subsidiaries, more than 6,500 employees, assets of over 10 billion yuan, and main business income of over 6 billion yuan. It has research and development, production and export of innovative drugs, generic drugs, specialty APIs, high-end preparations, biological preparations and The group has formed a full industrial chain from the research and development, production and application of specialty raw materials, new preparations to pharmaceutical packaging materials. The annual production capacity of injections can reach 4 billion (pieces/bottles/bags), and its production scale and technical level are at the forefront of the industry. Flexible operation methods, diversified marketing and services have enabled the group's brand products to win praise and reputation from customers and consumers. The products radiate across the country and are exported to more than 100 countries and regions overseas.